On 17 June 2021, Alzheimer Europe (AE) hosted an online Company Round Table meeting, attended by representatives from AbbVie, Biogen, EFPIA, Eisai, Fujirebio, GE Healthcare, Grifols, Lilly, Nutricia, Roche and TauRx. Also in attendance were: 7 members of the AE staff, including Executive Director Jean Georges; 28 representatives of AE member organisations from 22 different countries; and Chris Roberts, Chairperson of the European Working Group of People with Dementia (EWGPWD).
Kicking off the meeting, Alzheimer Europe Project Officer Cindy Birck gave an overview of recent clinical trial developments and an update on our Clinical Trials Watch database, whilst Policy Officer Owen Miller shared some recent policy developments at the EU and global levels.
Following these presentations, attendees heard from Nicolas Creff, Senior Manager Research partnerships at EFPIA (European Federation of Pharmaceutical Industries and Associations), who discussed Public-private partnerships in the new Horizon Europe programme, and introduced the Innovative Health Initiative (the new incarnation of what is currently the Innovative Medicines Initiative - IMI). Mr Creff's colleague Mihai Rotaru, Senior Manager Market Access, EFPIA, delivered a presentation on the new European framework for health technology assessments (HTAs).
Finally, Alzheimer Europe Executive Director Jean Georges updated sponsors and other delegates on Alzheimer Europe’s activities. In closing, he thanked sponsors and members for participating in the roundtable meeting. The next Company Round Table meeting, will take place on 28 September 2021.
